Core Viewpoint - The insurance capital is actively seeking investment opportunities in the stock market as it enters 2026, with a significant increase in company research activities, indicating a bullish sentiment towards various sectors [1][2]. Group 1: Investment Trends - As of February 1, 2026, insurance companies and their asset management firms conducted a total of 751 company research activities, reflecting a strong interest in identifying investment opportunities across hundreds of listed companies [1]. - The total investment balance of insurance companies reached 37.46 trillion yuan by the end of Q3 2025, marking a 3.39% increase from the previous quarter [1]. - Insurance capital is focusing on high-dividend stocks, particularly in the banking sector, while also expanding interest in emerging sectors such as artificial intelligence and biomedicine [2][3]. Group 2: Sector Focus - The primary sectors of interest for insurance capital include banking, computer science, artificial intelligence, biomedicine, and aerospace, with a focus on high-end manufacturing and new productivity drivers [2]. - Notable companies attracting attention from insurance capital include Haitai Ruisheng, Entropy Technology, and Aladdin, which are involved in AI data, biometric technology, and new materials, respectively [2]. - The banking sector remains a hotspot for insurance capital, with banks like Shanghai Bank and Nanjing Bank receiving significant attention due to their stable dividends, which align with the cash flow needs of insurance companies [3]. Group 3: Investment Strategy - Insurance capital is expected to maintain a cautious investment approach, focusing on high-dividend sectors while gradually increasing allocations to new productivity-related fields [4]. - The strategy includes a continued emphasis on bonds as a stable investment, while also exploring long-term local and cross-border bonds, and increasing equity allocations through private securities funds and strategic stakes [3][4]. - The investment pace of insurance capital is characterized by a careful wait for reasonable valuation levels and a cooling market sentiment before making gradual allocations, indicating a long-term investment perspective [4].

全球芯片产业链传来利好信号。 据最新数据，今年1月份，号称全球经济"金丝雀"的韩国出口半导体总金额达205亿美元（约合人民币 1425亿元），同比暴涨超102%。这预示着，在AI（人工智能）浪潮下，全球半导体需求仍非常强劲。 暴增超102% 2月1日，据韩国海关数据，韩国2026年1月半导体出口同比大幅增长102.7%，半导体出口额达205亿美 元，为连续两个月突破200亿美元，也是半导体出口史上第二高的月度纪录，并带动韩国1月出口总额增 加。 数据显示，韩国1月总出口额同比增长33.9%，为658.5亿美元，创下历史同期最高纪录。同期，韩国进 口额同比增长11.7%，为571亿美元。由此计算，韩国1月贸易收支实现87亿美元顺差。单月贸易收支连 续12个月实现顺差。 有分析指出，韩国是全球主要半导体出口国，拥有"存储芯片双雄"三星电子、SK海力士。随着全球AI 热潮大幅推升存储芯片需求，韩国成为最大的赢家之一。 除主力品类外，韩国的电气设备（19.8%）、农水产品（19.3%）和化妆品（36.4%）出口也均创下历年 1月新高。 相比之下，受全球供应过剩导致出口价格下跌的影响，石化产品出口额同比下降1.5%，至 ...

Core Viewpoint - Shanghai Suiruan Technology Co., Ltd. has received acceptance for its IPO application on the Sci-Tech Innovation Board, marking a significant step for domestic GPU companies in the capital market [22][23] Group 1: IPO Details - The company plans to issue no less than 43.0352 million shares and no more than 68.35 million shares, accounting for 10% to 15% of the total share capital post-issue, with a fundraising target of 6 billion yuan [22][24] - This fundraising amount is considered reasonable compared to peers, with Moer Thread aiming to raise 8 billion yuan and Muxi Co., Ltd. targeting 4.197 billion yuan during their respective IPOs [22] Group 2: Use of Proceeds - The raised funds will primarily be used for the R&D and industrialization of the fifth and sixth generation AI chip series, as well as advanced AI hardware and software collaborative innovation projects [24] Group 3: Founders and Team Background - The founders of Suiruan Technology, including CEO Zhao Lidong and COO Zhang Yalin, have extensive backgrounds in semiconductor giants like AMD and Nvidia, contributing to the company's strong technical foundation [25][26][28] - The core team is composed of members from major international chip companies and domestic leaders, ensuring a well-rounded expertise in chip design, algorithm development, and market sales [28] Group 4: Product Development and Strategy - Suiruan Technology has chosen a challenging path by developing dedicated accelerators for AI training and inference, creating a fully autonomous hardware and software ecosystem, unlike many peers who opt for CUDA compatibility [29][30] - The company has developed four generations of cloud AI chips, with a notable product release schedule, including the "Yunsui T10" training accelerator card in December 2019 and the "Suiruan S60" inference accelerator card in 2024 [31] Group 5: Financial Performance - The company has shown rapid revenue growth, with revenues of 90.1 million yuan in 2022, 301 million yuan in 2023, and 722 million yuan in 2024, reflecting a compound annual growth rate of 183.15% [32] - Despite the growth, the company has incurred significant losses, totaling 4.29 billion yuan over three years due to high R&D expenditures, which accounted for over 300% of revenue during that period [12][33] Group 6: Market Position and Competition - The domestic GPU market is projected to exceed 80 billion yuan by 2025, with a growth rate of over 60%, and Suiruan Technology is positioned as a representative of the ASIC route, focusing on deep customization for major clients like Tencent [41] - The company faces competition from Nvidia, which holds a dominant 70% market share in the Chinese AI accelerator card market, while domestic manufacturers have increased their share from 8.3% in 2022 to 17.4% in 2024 [42]

Core Insights - Haichuang Pharmaceutical's innovative drug, Deutetrabenazine (brand name: Hainan'an®), has successfully passed GMP compliance inspection, enabling large-scale commercial production [1] - The drug has been included in the 2025 National Medical Insurance Directory, providing a solid payment foundation for market expansion [1] - The combination of GMP certification and insurance inclusion creates a synergistic effect, completing the company's full industry chain from R&D to production and sales [1] Group 1: Product and Market Potential - Deutetrabenazine is the first domestic AR inhibitor approved for metastatic castration-resistant prostate cancer (mCRPC), filling a clinical gap in this area [2] - The domestic AR inhibitor market is rapidly growing, expected to reach 23.9 billion yuan by 2030, with the overall prostate cancer market exceeding 50 billion yuan [2] - The current market is dominated by foreign products, which hold 75% of the market share, indicating significant potential for domestic alternatives [2] Group 2: Pipeline Development - The activation of commercial production capacity will support not only the core product but also the pipeline reserves, ensuring scalable implementation [3] - The oral ARPROTAC drug HP518 is in clinical trials, showing potential for synergy with Deutetrabenazine in treating resistant prostate cancer [3] Group 3: Metabolic Disease Research - The drug HP515 for treating MASH has completed Phase I clinical trials, with Phase II trials ongoing, showcasing promising preclinical data in combination with GLP-1 drugs [4] - The combination therapy addresses the core issue of muscle loss associated with traditional weight loss drugs, catering to the needs of over 400 million overweight/obese individuals in China [5] - The global weight loss market is projected to reach $554.9 billion by 2030, indicating substantial growth potential in this sector [5] Group 4: Strategic Positioning - The dual breakthroughs of GMP certification and core product insurance inclusion signify the company's comprehensive capabilities in innovative R&D, large-scale production, and market promotion [5] - The company aims to leverage its mature production management system and full industry chain layout to enhance market penetration of core products and clinical transformation of pipeline products [5]

Investment Rating - The report maintains a rating of "Buy" for the mechanical equipment industry, with a focus on specific companies such as SANY Heavy Industry and Jiangsu HJT Equipment [1][35]. Core Insights - The report highlights significant opportunities in the photovoltaic equipment sector, particularly due to the dual demand from both ground and space applications, driven by initiatives like SpaceX's satellite deployment [2][25]. - The engineering machinery sector is expected to see a surge in activity as the construction season approaches, with historical data indicating a strong performance in Q1 [3][41]. - The report emphasizes the importance of AI-driven demand in various sectors, including the semiconductor and energy industries, which are expected to experience substantial growth [38][44]. Summary by Sections Photovoltaic Equipment - SpaceX's application for deploying a satellite constellation presents a unique opportunity for equipment manufacturers, with a projected demand for GW-level space photovoltaic solutions [2][25]. - The ground photovoltaic market is also experiencing robust demand, particularly in Europe and the U.S., with expectations of equipment demand reaching 70-90 GW [2]. Engineering Machinery - The report notes that Q1 typically sees a spike in machinery activity due to budget releases and favorable weather conditions, with excavator sales historically accounting for a significant portion of annual sales [3][41]. - Recommended companies in this sector include SANY Heavy Industry, XCMG, and LiuGong [3][41]. AI and Semiconductor Equipment - The report discusses the increasing demand for AI computing power, which is expected to drive growth in the semiconductor equipment market, particularly for companies involved in PCB and PCBA production [19][32]. - Companies like North Huachuang and Zhongwei are highlighted as key players benefiting from this trend [32]. Gas Turbine and Energy Equipment - The report identifies a growing demand for gas turbines due to the increasing electricity needs driven by AI data centers, with a projected supply gap in the market [29][30]. - Recommended companies in this area include Jereh and Yingliu, which are positioned to benefit from this demand surge [30]. Robotics and Automation - The anticipated mass production of Tesla's Optimus robot is expected to create opportunities for domestic component manufacturers, with companies like Hengli Hydraulic and New Coordinates being highlighted [45]. - The report suggests that the automation of assembly lines in the optical module sector is becoming a necessity due to the evolving market demands [20].

证券研究报告 2月十大金股推荐 1 ※ 核心观点 我们认为当前仍处于市场流动性偏宽的环境中，叠加高频景气跟踪与上市公司业绩预告均显示基本面有结构性亮点， 因此继续看好权益市场延续震荡向上趋势。方向上，建议重点关注：一是内外需共振景气向上、成长预期较好的科技 制造板块（AI/半导体/存储/风电等）；二是受益于产品涨价预期的周期板块（有色金属/化工等）；三是业绩有望筑 底改善的行业（建材/免税等）；四是部分绩优红利资产（保险等）。 资料来源：Wind，平安证券研究所 备注：本篇报告数据统计截至2026/1/29 平安证券研究所 2026年1月30日 请务必阅读正文后免责条款 2 证券代码 证券名称 申万一级行业 总市值 PE PB 推荐逻辑 （亿元人民币） (TTM) (MRQ) 300223.SZ 北京君正 电子 662 208.6 5.3 存储周期上行，L3智能驾驶催化汽车电子 603005.SH 晶方科技 电子 201 58.9 4.4 WLCSP先进封装领先企业，受益车规CIS需求扩张 688041.SH 海光信息 电子 6,073 256.6 27.7 国产算力领先企业，业绩持续增长可期 688615. ...

石油石化 2026 年 2 月 1 日 石油石化周报 伊朗地缘局势严峻，油价短期震荡偏强 强于大市（维持） 行情走势图 -40% -20% 0% 20% 40% 60% 24/01 24/03 24/05 24/07 24/09 24/11 25/01 25/03 25/05 25/07 25/09 25/11 26/01 沪深300 石油石化 基础化工 证券分析师 核心观点： 投资建议： 证 券 研 究 报 告 本周，我们建议关注石油石化、氟化工、半导体材料板块。石油石化：伊朗局势升级，美欧关系就格陵兰岛问题存在较大波折， 委内油供应能否增加尚存变数，短期内油价或呈现震荡偏强走势；中长期油价锚定基本面，随着 OPEC+增产的推进，美洲国家油 田的开发，基本面过剩格局或将继续演绎，油价仍存在中枢进一步下移的预期。面对国际油价剧烈震荡，国内油企通过上下 游一 体化布局和油气来源多元化降低了业绩对油价的敏感性，并加快在国内海上油气资源开放方面的投入，以降低能源对外依赖程 度。 建议关注增产空间大、成本有优势的中国海油、中曼石油，以及深入炼化一体化布局、降本增效成果较好、企业业绩表现出 较强 韧性的中国石油、恒力石 ...

Core Insights - The total market value of the scanning electron microscope (SEM) bidding market in 2025 is projected to reach 1.8 billion yuan, with 534 units procured, primarily driven by demand from East and North China, and universities being the main purchasers [1][4][6]. Market Overview - The SEM bidding market in 2025 is characterized by a total value of 1.8 billion yuan and a procurement of 534 units, with demand spanning 385 purchasing entities and 26 bidding brands, indicating a diverse competitive landscape [4]. - East China accounts for 27.7% of the procurement value, while North China follows with 22.2%, together representing nearly half of the total market [8]. - Universities, industrial enterprises, and research institutes dominate the purchasing landscape, collectively accounting for over 90% of the market [4][14]. Demand Structure - East and North China are identified as the core demand regions, with a significant concentration in both procurement value and quantity [8]. - In terms of purchasing entities, universities lead with a 58.6% share in monetary terms, followed by industrial enterprises at 19.2% and research institutes at 13.0% [14][15]. Brand Competition - Imported brands hold a dominant position in the SEM market, with a bidding amount share of 71.6% and a quantity share of 64.2%, while domestic brands account for 24.4% and 31.6%, respectively [18][22]. - In terms of monetary value, Thermo Fisher and Zeiss lead with 24.1% and 23.4% market shares, respectively, while Guoyi Quantum follows with 15.9% [20]. Product Distribution - Field emission scanning electron microscopes dominate the market, accounting for 57.4% of the bidding amount, while tungsten filament SEMs represent only 7.8% [23]. - The average bidding prices for different types of SEMs show significant variation, with field emission SEMs averaging 3.724 million yuan [26]. Popular Models - Guoyi Quantum has the highest number of models listed among the popular bidding models, with four models making the list, reflecting its strong market presence [28]. - The top models include Hitachi SU8600 with 43 units, Zeiss Sigma360 with 29 units, and several models from Guoyi Quantum, indicating a robust product lineup [27].

Group 1 - The core logic of global capital reallocation has shifted, with a growing consensus that "the next China" is still China, as highlighted by Estee Lauder's CEO at the Davos Forum [1] - Morgan Stanley's report indicates that in 2025, the US dollar index depreciated by 10%, while foreign capital inflow into the Chinese stock market reached $50.6 billion, significantly surpassing the total of $11.4 billion for 2024 [2] - The geopolitical landscape in 2026 shows a stark contrast, with the East stabilizing as China engages in trade agreements and the West facing challenges such as tariff threats and leadership disputes [2] Group 2 - The "East stable, West shaky" situation is prompting a reevaluation of capital allocation strategies, as traditional safe-haven assets like the US dollar are losing appeal, while gold's share in global reserves has risen to about 25% [4] - Central banks are increasingly favoring gold, reflecting concerns over the erosion of trust in fiat currencies, with the share of the renminbi in bilateral trade settlements rising and offshore renminbi bond issuance hitting record highs [6] - China's economy is experiencing a dual-track development, with traditional sectors adjusting and new productivity rapidly growing, despite a 30% decline in housing prices [8][10] Group 3 - In 2026, macroeconomic policies are set to be "moderately expansive," focusing on targeted measures rather than broad stimulus, with a consumer spending stimulus of no less than 300 billion yuan [10] - The new energy vehicle sector has seen monthly sales surpassing 50% of total new car sales for the first time in October 2025, indicating a significant shift in the automotive market [12] - Investment focus is shifting towards AI and green transformation, with AI applications expected to accelerate commercialization in 2026, while China's strengths lie in effectively translating technology into productivity [14][16] Group 4 - The investment demand for achieving carbon peak and carbon neutrality is projected to exceed 2% of GDP, creating substantial investment opportunities, particularly in energy storage [18] - The aerospace sector is highlighted as a future competitive field, suggesting a need for investors to adopt a "barbell strategy" that balances high-growth stocks with stable dividend assets [18] - China's innovation clusters, particularly in Beijing, Shanghai, and the Guangdong-Hong Kong-Macau Greater Bay Area, are positioned to drive future economic growth, attracting capital that aligns with technological innovation and green transformation [20]

Core Viewpoint - The article highlights the success story of Atongmu Robotics, which has transformed from a small startup to a leading player in the parallel robot market in China, achieving significant returns for early investors and recently filing for an IPO [3][19]. Company Overview - Atongmu Robotics was founded by Liu Songtao and his partner Song Tao, both graduates of Tianjin University, with a vision to liberate blue-collar workers in China through automation [7][11]. - The company has grown from a team of about 10 to over a hundred employees, becoming the top domestic brand in the parallel robot market and surpassing foreign competitors [18][30]. Investment Journey - The company received an angel investment of 666.67 million RMB in 2015, which has since grown to a valuation of over 2.5 billion RMB [19][29]. - Notable investors include Yang Haoyong, CEO of Guazi, and Wang Tianmiao, a professor at Beihang University, who recognized the potential of Atongmu's technology and market opportunity [20][24]. Financial Performance - Atongmu's revenue increased from 93 million RMB in 2023 to 157 million RMB in the first three quarters of 2025, with a gross margin improvement from 17% to 28.9% during the same period [34][35]. - The company achieved a net profit of 93.8 million RMB in the first three quarters of 2025, although the net profit margin remains low at 0.6% [35][39]. Market Position - The global parallel robot market is projected to reach between 7.8 billion to 11.5 billion RMB by 2029, with China expected to grow at a compound annual growth rate of approximately 13% from 2024 to 2029 [31][39]. - Atongmu has established itself as a leader in the domestic market, holding the highest market share for five consecutive years and becoming the largest supplier of parallel robots in the Chinese new energy sector [18][30]. Competitive Landscape - The company faces competition from international giants like ABB and Stäubli, as well as domestic rivals such as Yifei Intelligent Technology [33][39]. - Atongmu's competitive advantage lies in its established technology and market position, having achieved significant milestones in product development and market penetration [34][39]. Future Challenges - The company must navigate challenges related to improving profitability and cash flow while continuing to invest in new product development to maintain its competitive edge [40].